Clin2
NCT07040566Possibly a fitRecruiting

Varenicline to help stop vaping

E-cigarette UseVapingNicotine Dependence

Treatments studied

Part of Mental health clinical trials.

This trial tests whether varenicline, a medicine that reduces cravings, can help people quit using e-cigarettes that contain nicotine. You must be a daily nicotine vaper and live in Connecticut or South Carolina.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
326 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You use a nicotine e-cigarette every day
  • You live in Connecticut or South Carolina
  • You do not regularly use other tobacco products like cigarettes or chew
  • You have no medical condition that prevents using varenicline
  • You are not currently in treatment to stop smoking or vaping
  • You can understand English well enough to participate

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07145866Recruiting· Phase 4
Varenicline and TMS for quitting nicotine use

This study tests whether combining the medication varenicline (Chantix) with a special brain stimulation treatment (TMS) can help people quit vaping or smoking nicotine. If you're motivated to quit and use nicotine daily, you may be able to join.

Boston, Massachusetts
NCT06688539Recruiting· Phase 4
Quitting e-cigarettes in adults who also use cannabis

This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.

Charleston, South Carolina
NCT07786896Not yet recruiting· Phase 4
Quitting vaping with nicotine replacement therapy

This study tests whether nicotine replacement therapy (like patches or gum) helps people who regularly vape nicotine stop vaping. If you're interested in quitting in the next few months, this study may be able to support you.

Greenville, North Carolina
NCT07322432Recruiting· Phase 2
The CONQUER trial: quitting vaping with e-cigarette reduction

This study tests whether gradually reducing nicotine in e-cigarettes helps people who vape quit completely. It is for adults who are ready to stop and want a structured program.

New York, New York
NCT05703672Recruiting· Phase 3
Switching smokers to e-cigarettes who do not want to quit

This study tests whether switching from regular cigarettes to e-cigarettes helps smokers who are not interested in quitting. You would also be offered varenicline and regular check-ins to compare outcomes over time.

Kansas City, Missouri
NCT06883162Recruiting· Phase 3
A study to help people stop smoking tobacco and reduce cannabis use

This study tests whether a medication called varenicline (or a placebo) can help people who use both tobacco and cannabis to quit or cut back. It takes place in South Carolina and lasts 12 weeks.

Charleston, South Carolina

Hear when a new E-cigarette Use trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.